Yasuyuki Otsuka
Kitakyushu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Post-transplant lymphoproliferative disease of two different histological types.
Journal: Annals of hematology
Published: February 15, 2024
Epitope Mismatch at HLA-DRB1 Associates with Reduced Relapse Risk in Cord Blood Transplantation for Standard-Risk Hematologic Malignancy.
Journal: Transplantation and cellular therapy
Published: November 23, 2022
Allogeneic stem cell transplantation for trisomy 8-positive myelodysplastic syndrome or myelodysplastic/myeloproliferative disease with refractory Behçet's disease: Case report and the review of literature.
Journal: Modern rheumatology case reports
Published: January 17, 2022
Treatment for acute leukemia showing PCR-positivity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) at initial diagnosis: a case report and review of literature
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 06, 2021
A sporadic case of CTLA4 haploinsufficiency manifesting as Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: October 28, 2021
A case report of combined treatment of gilteritinib and LH-RH agonist for Fms-related tyrosine kinase 3 receptor mutation-positive acute myeloid leukemia and bone marrow metastasis of prostate cancer.
Journal: Annals of hematology
Published: February 10, 2021
Relapse of follicular lymphoma arising from a non-t(14;18) clone.
Journal: EJHaem
Published: April 23, 2020
Programmed cell death 1-expressing CD56-negative natural killer (NK) cell expansion is a hallmark of chronic NK cell activation during dasatinib treatment.
Journal: Cancer science
Published: March 16, 2020
Establishment and characterization of a MALT lymphoma cell line carrying an API2-MALT1 translocation.
Journal: Genes, chromosomes & cancer
Published: December 27, 2019
Successful treatment with recombinant thrombomodulin in transplant-associated thrombotic microangiopathy following HLA-haploidentical transplantation
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 17, 2019
EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas.
Journal: Molecular immunology
Published: September 16, 2019
Last Updated: 09/26/2026